Effective from 17 May 2024 Definitive fees charged for applications under Schedule 7 of Veterinary Medicines Regulations 2013 (as amended) as they apply to GB.
Veterinary Medicines Directorate
- Research: Bovine TB epidemiology and surveillance in Great Britain, 2023
- Council Tax Manual
- Council Tax: practice notes
- Section 2: maintenance of Council Tax lists - billing authority reports and altering lists
- Guidance: Priority change of circumstances for sponsors
- Guidance: Two-Way Satellite Time and Frequency Transfer (TWSTFT) Capability Project
- Guidance: Changes to SIA rules for LDNs: your questions answered
- Changes to the rules for SIA licence dispensation notices (LDNs)
- Press release: PM meeting with President Subianto of the Republic of Indonesia: 21 November 2024
- Guidance: Rights of Way order information: Decisions and maps published in 2023 and 2024
This UK VARSS report provides the details of UK veterinary antibiotic resistance and sales surveillance.
This UK VARSS report provides the details of UK veterinary antibiotic resistance and sales surveillance.
Marketing Authorisations Veterinary Information Service (MAVIS) Hub edition 132.
Reporting against VMD published standards up to 31 March 2025.
Prescribing or supplying veterinary medicines including requirements for registration and inspection of premises.
Document for the Veterinary Medicines Directorate annual report and accounts 2023 to 2024.
References and list of enforcement notices and prosecutions which involved illegal activity with animal medicines in the last year.
This UK VARSS report provides the details of UK veterinary antibiotic resistance and sales surveillance.
Validation for applications during the Christmas period 2024 for MA, ManA, WDA, Batch Release, Specific Batch Control, and Special Import and Export Certificates.
General licence for using the inactivated BTV-3 vaccine in England.
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 July to 30 September 2024.
Urgent and clinically significant safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
Increased discussion of suspected adverse events in social media following use of Arthramid Vet in horses.
Advice from the UK Chief Veterinary Officer to veterinarians prescribing BTV-3 vaccines.
Reporting against VMD published standards up to 31 March 2025.
Residues of veterinary medicines in food 2024 surveillance results, a rolling summary.
Residues of veterinary medicines in food 2024 surveillance results, a rolling summary.
The VMD’s online services will be unavailable from 6am Saturday 12 October until 8pm Sunday 13 October due to essential site maintenance.
Guidelines and guidance for vets, farmers and animal keepers on the responsible use of antimicrobials.
Senior Pharmacovigilance Assessor vacancy, working in the VMD Authorisations Division.
General licence for using the inactivated BTV-3 vaccine in England.
Administrative Officer vacancy, working within the VMD.
How a marketing authorisation holder should report a defect with a veterinary medicine.
Changes to when the VMD requires submission of veterinary medicine labelling mock-ups for assessment.
Product defect recall alert for Prednicare 1 mg Tablets Vm 32742/4034 by Ecuphar N.V.
General licence for using the inactivated BTV-3 vaccine in England.
Reporting against VMD published standards up to 31 March 2025.
References and list of enforcement notices and prosecutions which involved illegal activity with animal medicines in the last year.
Accounts Payable Manager vacancy, working in the VMD Finance Team.
General licence for using the inactivated BTV-3 vaccine in England.
Advice from the UK Chief Veterinary Officer to veterinarians prescribing BTV-3 vaccines.
How to obtain an authorisation to wholesale veterinary medicines.
How veterinary medicines can be advertised.
Summary of the Animal Sentience Committee’s findings regarding amendments to the Veterinary Medicines Regulations 2013 and the government response to their recommendations.
References and list of enforcement notices and prosecutions which involved illegal activity with animal medicines in the last year.
Senior Application Manager vacancy, working in the regulation of veterinary medicines.
The Secretary of State for Defra has permitted the use of 3 unauthorised bluetongue serotype 3 (BTV-3) vaccines within the UK, subject to licence.
Apply for an authorisation to manufacture extemporaneous preparations, autogenous vaccines, stem cell products or blood products for non-food animals.
The Secretary of State for Defra has permitted the use of 3 unauthorised bluetongue serotype 3 (BTV-3) vaccines within the UK, subject to licence.
The Secretary of State permitted the use of 3 unauthorised bluetongue serotype 3 (BTV-3) vaccines within the United Kingdom yesterday (4 September).
Revisions to the charges for delivering the statutory annual surveillance programme in England, Scotland and Wales.
Summary of product characteristics for Syvazul BTV-3 vaccine in the UK
Summary of product characteristics for BLUEVAC-3 BTV-3 vaccine in the UK
References and list of enforcement notices and prosecutions which involved illegal activity with animal medicines in the last year.
Ministerial Departmental News
- PM's Office, 10 Downing Street
- Cabinet Office
- Department for Business, Innovation and Skills
- Department for Communities and Local Government
- Department for Culture, Media and Sport
- Department for Education
- Department for Environment, Food and Rural Affairs
- Department for International Development
- Department for Transport
- Department for Work and Pensions
- Department of Energy and Climate Change
- Department of Health
- Foreign and Commonwealth Office
- HM Treasury
- Home Office
- Ministry of Defence
- Ministry of Justice
- Northern Ireland Office
- Scotland Office
- Wales Office
- See all departments